- ALDISA SR is indicated for reduce the nasal congestion
symptoms, sneezing, rhinorrhea, pruritus and
lacrimation which are associated with allergic rhinitis
and the common cold.
- ALDISA SR should be administered when both the
antihistaminic properties of Loratadine and the nasal
deconges

Dossage

Adults and children ³ 12 years: 1 capsule, twice a day.

Precaution

- It should be used with caution in patients with glaucoma,
peptic ulcer, stenosis, pyloroduodenal obstruction,
cardiovascular disease, hypertension,
diabetes mellitus, ischemic heart disease, increased
intraocular pressure, hyperthyroidism, renal impairment
or prostatic hypertrophy.
- It should be avoided in patients with hepatic
insufficiency.
- Patients with renal insufficiency (GFR < 30 ml/min)
should be given a lower initial dose (1 capsule per day)
because they have reduced clearance of Loratadine
and Pseudoephedrine.
- It should be used in pregnancy and during lactation
only if the potential benefit justifies the potential risk to
the fetus or nursing infant.
- Safety and effectiveness in children below the age of
12 years have not been established.
- Sympathomimetics may cause CNS stimulation, excitability,
convulsion and/or cardiovascular collapse
with accompanying hypotension.
- In elderly patients (³ 60 years), sympathomimetic
amines are also more likely to cause adverse reactions,
e.g. confusion, convulsions, hallucination, CNS depression
and death.
Consequently, caution should be exercised when
administering to elderly patients.
- At high doses, Pseudoephedrine Sulphate commonly
experience an elevation of mood, decreased appetite
and a sense of increased physical energy, mental
capacity and alertness. Anxiety, irritability and
loquacity also have been experienced. With continued
use, tolerance develops, the user increases the
dose and ultimately toxicit

- Relieves symptoms associated with allergic rhinitis, such
as sneeze, nasal discharge, and itchiness as well as
ocular itchiness and burning.
- Relieves symptoms associated with chronic urticaria
and other dermatologic diseases

- Patients with severe liver impairment should be given a
lower initial dose, due to its possibility of lowering
Loratadine clearance, recommended initial dose is
5 mg a day or 10 mg every 2 days.
- Efficacy and safety of Loratadine use in children under
2 years of age have not been established.
- The safety of Loratadine during pregnancy has not
been established, it is used only if the potential benefit
justifies the potential risk to fetus.
- It should be used with caution in nursing women since
Loratadine passes easily into breast milk.

ALLORIS ® is indicated for the relief of symptoms associated with allergic rhinitis, such as sneezing, nasal discharge and itching as well as ocular itching and burning.

ALLORIS® is also indicated for the relief of the symptoms associated with chronic urticaria and other allergic dermatologic disorders.

Dossage

Adults and children 12 years: 1 tablet daily

Precaution

- Loratadine should be administered during pregnancy, since there is no experience of the use of Loratadine in pregnant women.
- Since Loratadine is excreted in breast milk it should not be administered to lactating women.
- Safety and efficacy of Loratadine in children under 12 years of age has not yet been established.
- Studies to establish safety and efficacy in the elderly patients are not yet completed.

CERINI is indicated for the treatment of perennial rhinitis, seasonal allergic rhinitis and chronic idiopathic urticaria.

Dossage

Adults and children > 6 years of age : 1 caplet (10 mg) daily.
- Safety for use in children < 2 years of age has not been established.
- There are no data to suggest that the dose needs to be reduced in elderly patients.
- In patients with renal insufficiency dosage should be given ½ caplet daily.

Precaution

- Patients are advised not to exceed the recommended dose if driving or operating machinery.
- It should be used with caution in pregnancy women.

Tablets are indicated to treat cases Allergies and inflammation that require therapy with corticosteroids

Dossage

Dose adjusted to the condition of the sufferer Treated and responses obtained.

Adults and children over 12 years: - Starting dose : 1 - 2 tablets, 3 - 4 times daily, after meals and on While going to bed. Can not be more than 8 tablets a day.

- Children under 12 years : Dose adjustment by weight / light condition Disease, better than age or weight body.

Precaution

- Be careful in elderly patients or children
Under 12 years of age.
- Not recommended for children
Under 6 years.
Growth and development of infants and children
Who received corticosteroid treatment
The long term should be carefully observed.
- Sensitivity to infection in patients who
Getting a corticosteroid is not specific to
Bacteria or certain pathogenic fungi.
When an infection occurs, the dose is maintained or
Plus and should be treated that
right.
- Corticosteroids are not recommended for use on
First trimester pregnancy, as it may occur
Hypoadrenalism in neonates.
- Not recommended for use in breastfeeding women
Because small amounts of corticosteroids are secreted
Into breast milk.
- Adrenocortical insufficiency secondary to use
Drugs, can be reduced by decreasing the dose on a regular basis
gradually.
- Not recommended aspirin together
With corticosteroids in patients with hypoprotrombinemia.
- Avoid sudden treatment cessation after
Old usage.
- Older usage may increase vulnerability
Against infection.
- There is an increase in the effect of corticosteroids in patients
With hypothyroidism and cirrhosis.
- Must be used with caution in patients
With diabetes mellitus as it can improve
Gluconeogenesis and reduced sensitivity
Against insulin.